[No abstract available]53SPEC. ISS.166174Lee, T.H., Cook, E.F., Weisberg, M.G., Acute chest pain in the emergency room. Identification and examination of low-risk patients (1985) Arch Intern Med, 45, pp. 65-69Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction (1986) Lancet, 1, pp. 397-401Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17.187 cases of suspected acute myocardial infarction: ISIS-2 (1988) Lancet, 2, pp. 349-401Third International Study of Infarct Survival (ISIS-3): A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases suspected acute myocardial infarction, ISIS-3 (1992) Lancet, 339, pp. 753-770Goldman, L., Cook, E.F., Brand, D.A., A computer protocol to predict myocardial infarction in emergency department patients with chest pain (1992) N Engl J Med, 318, pp. 797-803Rouan, G.W., Lee, T.H., Cook, E.F., Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or non-specific eletrocardiograms (1989) Am J Cardiol, 64, pp. 1087-1092Indications for fibrinolytic therapy in suspected acute myocardial Infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients (1994) Lancet, 343, pp. 311-322Cunningham, M.A., Lee, T.H., Cook, E.F., The effect of gender on the probability of myocardial infarction among emergency department patients with acute chest pain. A report from the Multicenter Chest Pain Study (1989) J Gen Intern Med, 4, pp. 392-398Lee, T.H., Weisberg, M.C., Cook, E.F., Evaluation of creatine kinase and creatine kinase - MB for diagnosing myocardial infarction. Clinical impact in the emergency room (1987) Arch Intern Med, 147, pp. 115-121Clyne, C.A., Medeiros, L.J., Marton, K., The prognostic significance of immunoradiometric Ck-MB assay (IRMA) diagnosis of myocardial infarction in patients with low total CK and elevated MB isoenzimes (1989) Am Heart J, 118, pp. 901-906Puleo, P.R., Guadagno, P.A., Roberts, R., Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB (1990) Circulation, 82, pp. 759-764Gibson, R.S., Bishop, H.L., Stamm, R.B., Value of early two-dimensional echocardiography in patients with acute myocardial infarction (1982) Am J Cardiol, 49, pp. 1110-1119Hauser, A.M., Gangadharan, V., Ramos, R.G., Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: Echocardiographic observations during coronary angioplasty (1985) J Am Coll Cardiol, 5, pp. 193-197Sabia, P., Afrookleh, A., Touchstone, D.A., Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction: A prospective study using two-dimensional echocardiography (1991) Circulation, 84 (1 SUPPL.), pp. I85-I92Gersh, B.J., Nonivasive imaging in acute coronary disease: A clinical perspective (1991) Circulation, 84 (1 SUPPL.), pp. I140-I147Erbel, R., Daniel, W., Visser, C., Echocardiographyin diagnosis of aortic dissection (1989) Lancet, 1, pp. 457-461De Franco, A., Topol, E., Invasive strategies in acute myocardial infarction in the elderly (1994) Cardiol Elderly, 2 (3), pp. 274-289Lee, T.H., Rouan, G.W., Weisberg, M.C., Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization (1987) Ann Intern Med, 106, pp. 181-186Lee, T.H., Juarez, G., Cook, E.F., Ruling-out acute myocardial infarction. a prospective validation of a 12-hour strategy for low-risk patients (1991) N Engl J Med, 324, pp. 1239-1246Gaspoz, J.M., Lee, T.H., Cook, E.F., Outcome of patients who were admitted to a new short-stay unit to rule-out myocardial infarction (1991) Am J Cardiol, 68, pp. 145-149Sharkey, S.W., Brunette, D.D., Ruiz, E., An analysis of time delays preceding thrombolysis for acute myocardial infarction (1989) JAMA, 262, pp. 3171-3174Granger, C.B., Califf, R.M., Topol, E.J., Thrombolytic therapy for acute myocardial infarction: A review (1992) Drugs, 44, pp. 293-325Muller, D.W., Topol, E.J., Ellis, S.G., Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction - TAMI-5 Study Group (1991) J Am Coll Cardiol, 18, pp. 1594-1601Sane, D.C., Califf, R.M., Topol, E.J., Bleeding during thrombolytic therapy for acute myocardial infarction: Mechanisms and management (1989) Ann Intern Med, 111, pp. 1010-1022The effects of tissue plasminogen activator, streptpkinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction (1993) N Engl J Med, 329, pp. 1615-1622Ellis, S.G., Van De Werf, F., Ribeiro Da Silva, E., Present status of rescue coronary angioplasty: Current polarization of opinion and randomized trials (1992) J Am Coll Cardiol, 19, pp. 681-686Brott, T., Thalinger, K., Hertzberg, V., Hypertension as a risk factor for spontaneous intracerebral hemorrhage (1986) Stroke, 17, pp. 1078-1083O'Connor, C.M., Califf, R.M., Massey, E.V.V., Stroke and acute myocardial infarction in the thrombolytic era: Clinical correlates and long-term prognosis (1990) J Am Coll Cardiol, 16, pp. 533-540Verstraete, M., Miller, G.A., Bounameaux, H., Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism (1988) Circulation, 77, pp. 353-360Althouse, R., Weaver, W.D., Kennedy, J.W., Transient elevation of diastolic blood pressure in the acute myocardial infarction - A contraindication to thrombolytic therapy? (1987) Circulation, 76, pp. IV-306Tenaglia, A.N., Califf, R.M., Candela, R.J., Thrombolytic therapy in patients requiring cardiopulmonary resuscitation (1991) Am J Cardiol, 68, pp. 1015-1019Marder, V.J., Sherry, S., Thrombolytic therapy: Current status (1988) N Engl J Med, 318, pp. 1512-1520Braunwald, E., Knatterud, G.L., Passamani, E., Update from the thrombolysis in myocardial infarction trial (1987) J Am Coll Cardiol, 10, p. 970An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction (1993) N Engl J Med, 329, pp. 673-682White, H.D., Thrombolytic Therapy for patients with myocardial infarction presenting after six hours (1992) Lancet, 340, pp. 221-222Braunwald, E., Myocardial reperfusion. Limitation of infarct size and improved survival: Should the paradigm be expanded? (1989) Circulation, 79, pp. 441-444Van De Werf, F., Discrepancies between the effects of coronary reperfusion on survival and left ventricular function (1989) Lancet, 1, pp. 1367-1369Sherry, S., Marder, V.J., Mistaken guidelines for thrombolytic therapy of acute myocardial infarction in the elderly (1991) J Am Coll Cardiol, 17, pp. 1237-1238Greenland, P., Reicher-Reiss, H., Goldbourt, U., In-hospital and year mortality in 1524 women after myocardial infarction. Comparison with 4315 men (1991) Circulation, 83, pp. 484-491Chesebro, J.H., Knatterud, G., Roberts, R., Thrombolysis in myocardial infarction (TIMI) trial. Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge (1987) Circulation, 76, pp. 142-154Califf, R.M., O'Neil, W., Stack, R.S., Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis (1988) Ann Int Med, 108, pp. 658-662Timmis, A.D., Griffin, B., Crick, J.C., The effects of early coronary patency on the evolution of myocardial infarction: A prospective arteriographic study (1987) Br Heart J, 58 (4), pp. 345-351Goldberg, S., Urban, P., Greenspon, A., Limitation of infarct size with thrombolytic agents - Electrocardiographic indexes (1983) Circulation, 68 (1 SUPPL.), pp. 177-182Hackworthy, R.A., Sorensen, S.G., Fitzpatrick, P.G., Effect of reperfusion on electrocardiographic and enzymatic infarct size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction (1988) Am Heart J, 116 (4), pp. 903-914De Ambrogg, L., Berlon, T., Marangoni, E., The Italian Group for the Study of Streptokinase in Myocardial Infarct: Changes in surface cardiac potentials. Study with chest electromaps (1987) G Ital Cardiol, 17 (1), pp. 63-72Markis, J.E., Dervan, J.P., Noninvasive indices in the early assessment of coronary artery reperfusion (1984) Circulation, 70 (2 SUPPL.), p. 332Nicolau, J.C., Lorga, A.M., Garzon, S.A.C., Clinical and laboratory signs of reperfusion: Are they reliable? (1989) Int J Cardiol, 25, pp. 313-320McGrath, K.G., Patterson, R., Anaphylatic reactivity to streptokinase (1984) JAMA, 252, pp. 1314-1317Honan, M.B., Harrel, F.E., Reimer, K.A., Cardiac rupture, mortality and the timing of thrombolytic therapy: A metanalysis (1990) J Am Coll Cardiol, 16, pp. 359-367Flather, M.D., Avezum, A., Yusuf, S., General Approach to Management of Acute Myocardial Infarction (1996) Atherosclerosis and Coronary Artery Disease, pp. 939-954. , Fuster V, Ross R, Topol EJ, eds. Philadelphia: Lippincott Raven PublishersPiegas, L.S., Avezum, A., Tratamento Adjuvante do Infarto Agudo do Miocárdio (1994) SOCESP - Cardiologia - Atualização e Reciclagem, pp. 305-315. , Barreto ACP, Sousa AGMR, eds. Rio de Janeiro: AtheneuWarnica, J.W., The pharmacologic management of acute myocardial infarction (1991) Acute Myocardial Infarction, pp. 205-217. , Gersch BJ, Rahintoola SH, eds. New York: Elsevier ScienceGuidelines for the early management of patients with acute myocardial infarction (1990) J Am Coll Cardiol, 16, pp. 249-292Hsia, J.A., Ross, A., Pharmacologic Adjuncts to thrombolysis for acute myocardial infarction (1992) Coronary Artery Disease., 3, pp. 103-108Bleich, S.D., Nichols, T.C., Schumacker, R.R., Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acte myocardial infarction (1990) Am J Cardiol, 66, pp. 1412-1417GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction (1990) Lancet, 336, pp. 65-71Prins, M.H., Hirsh, J., Heparin as an adjuntive treatment after thrombolytic therapy for acute myocardial infarction (1991) Am J Cardiol, 67, pp. 3A-11AHeld, P., Yusuf, S., Early intravenous beta-blockade in acute myocardial infarction (1989) Cardiology, 76, pp. 132-143Yusuf, S., Sleight, P., Held, P., Routine medical management of acute myocardial infarction (1990) Circulation, 82 (3 SUPPL.), pp. 117-134Roberts, R., Rogers, W.J., Mueller, S.H., Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. TIMI IIB Study (1991) Circulation, 83, pp. 422-437Randomized trial of intravenous atenolol among (16-027) cases of suspected acute myocardial infarction (1986) Lancet, 2, pp. 57-65McAlpine, H.M., Morton, J.J., Leckie, B., Rumley, A., Gillen, G., Dargie, H.J., Neuroendocrine activation after acute myocardial infarction (1988) Br Heart J, 60, pp. 117-124Michorowski, B.L., Ceremuzynski, L., The reninangiotensin-aldosterone system and the clinical course of acute myocardial infarction (1983) Eur Heart J, 4, pp. 259-264ACE inhibitors after myocardial infarction (1989) Lancet, 2, pp. 1133-1134Bennet, L.Z., Willian, R.L., Design and optimization of dosage regimen: Pharmacokinetic data (1990) The Pharmacological Basis of Therapeutics. 8th Ed., pp. 1650-1735. , Goodman and Gilman A, eds. New york. Pergamon PressSharpe, N., Smith, H., Murphy, J., Greaves, S., Hart, H., Gamble, G., Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition (1991) Lancet, 337, pp. 872-876Flather, M., Pipilis, A., Collins, R., Randomized controlled trial of oral captopril, of oral isossorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: Safety and haemodynamic effects (1994) Eur Heart J, 15, pp. 608-619A randomized trial of oral captopril versus placebo, oral mononitrate versus placebo, and intravenous magnesium versus control among 58,043 patients with suspected acute myocardial infarction (1995) Lancet, 345, pp. 669-685GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate after acute myocardial infarction (1994) Lancet, 343, pp. 1115-1122Held, P., Yusuf, S., Effects of beta-blockers and calcium channel blockers in acute myocardial infarction (1993) Eur Heart J, 14 (SUPPL. F), pp. 18-25Yusuf, S., Furberg, C.D., Effects of calcium channel blockers on survival after myocardial infarction (1987) Cardiovasc Drugs Ther, 1, pp. 343-344Yusuf, S., Held, P., Furberg, C., Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish verapamil infarction trial (DAVIT-II) and other recent studies (1991) Am J Cardiol, 67, pp. 1295-1297Norris, R.M., Bamaby, P.F., Brown, M.A., Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol (1984) Lancet, 2, pp. 883-886Goldberg, S., Greenspoon, A.J., Urban, P.L., Reperfusion arrhytmias: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction (1983) Am Heart J, 105, pp. 32-36Solomon, S.D., Ridker, P.M., Antman, E.M., Ventricular arrhytmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis (1993) Circulation, 88, pp. 2575-2581Kuck, K.H., Schofer, J., Schluter, M., Reperfusion arrhytmias in man - Influence of intravenous lidocaine (1985) Eur Heart J, 6, pp. 163-167